• Organic Cation Transporters and Xenobiotic Removal in Aedes

  2026-05-12

  Kennel and Rouhier (2025) investigated how Aedes aegypti mosquitoes respond to exposure to synthetic dyes, focusing on the physiological role and gene expression of putative organic cation transporters (OCTs/OCTNs). Their findings reveal that xenobiotic molecular structure, rather than transporter gene regulation, strongly influences excretion and toxicity, highlighting new molecular targets for mosquito control.

• Tapuy Lees Attenuate Neurodegeneration in C. elegans Disease

  2026-05-11

  Remucal et al. demonstrate that Tapuy lees, a by-product of traditional Filipino rice wine, significantly reduce amyloid-β toxicity and dopaminergic neurodegeneration in C. elegans models of Alzheimer’s and Parkinson’s diseases. The study highlights the superior antioxidant and neuroprotective properties of Tapuy lees over the wine itself, suggesting a novel direction for food-derived neurotherapeutics.

• Xenobiotic Transporter Response to Olsalazine in Aedes aegyp

  2026-05-11

  Kennel and Rouhier (2025) provide new insight into how Aedes aegypti mosquitoes handle synthetic xenobiotics such as Olsalazine Sodium and alizarin dyes. The study’s molecular and physiological findings inform potential strategies for vector control by characterizing the impact of xenobiotic structure on excretion, mortality, and transporter gene expression.

• Nonivamide (Capsaicin Analog): Applied TRPV1 Agonist Workflo

  2026-05-10

  Nonivamide, a selective TRPV1 agonist, is redefining cancer and neuroimmune assay design by enabling robust, reproducible apoptosis induction and inflammation modulation. This article translates recent mechanistic discoveries and experimental protocols into actionable guidance for leveraging Nonivamide in advanced in vitro and in vivo research.

• Ferroptosis Gene Signature and Atorvastatin in HCC Prognosis

  2026-05-09

  This study introduces a prognostic signature based on ferroptosis-related genes for hepatocellular carcinoma (HCC) and identifies atorvastatin as a candidate therapeutic agent. The findings provide both a predictive biomarker model and experimental validation of an HMG-CoA reductase inhibitor as a ferroptosis inducer in HCC.

• Macrophage EV miR-660 Drives Breast Cancer via KLHL21/NF-κB

  2026-05-08

  This study reveals that tumor-associated macrophage-derived extracellular vesicles containing microRNA-660 enhance breast cancer metastasis by targeting KLHL21 and activating NF-κB p65 signaling. These insights clarify a key route for immune-mediated tumor progression and highlight potential molecular intervention points.

• Berberrubine Chloride: Applied Cancer & Metabolic Research W

  2026-05-08

  Berberrubine chloride offers researchers a multi-target tool for probing cancer, inflammation, and metabolic disorders. Discover evidence-based protocols, troubleshooting expertise, and cross-domain assay workflows that maximize the translational impact of this potent, DMSO-soluble alkaloid.

• I-BET-762 BET Inhibitor: Workflow Optimization in Cancer and

  2026-05-07

  I-BET-762, a highly selective BET inhibitor from APExBIO, streamlines both epigenetic and ferroptosis workflows in translational research. This article delivers evidence-driven guidance on protocol optimization, troubleshooting, and leveraging I-BET-762 for advanced anti-inflammatory and oncology models.

• STAMBPL1/TRIM21 Axis Regulates Immune Evasion in KIRC via AX

  2026-05-07

  This study delineates how STAMBPL1 modulates AXL stability by antagonizing TRIM21-mediated ubiquitination, driving mesenchymal transition and immune evasion in kidney renal clear cell carcinoma (KIRC). The discoveries highlight the potential of targeting the STAMBPL1/TRIM21/AXL pathway to counteract immunotherapy resistance and improve therapeutic outcomes.

• (-)-Epigallocatechin Gallate (EGCG): Mechanisms & Research U

  2026-05-06

  (-)-Epigallocatechin gallate (EGCG) is a major green tea catechin with robust antioxidant, antiangiogenic, and antiviral properties. EGCG modulates apoptosis, cell cycle, and signaling pathways, making it a versatile research tool for oncology and inflammation studies. This article provides evidence-backed guidance for EGCG's use, applications, and boundaries.

• Mubritinib–Human Serum Albumin Binding: Implications for Dru

  2026-05-06

  This article analyzes the molecular recognition mechanisms between the mitochondrial electron transport chain inhibitor mubritinib and human serum albumin (HSA). The study reveals moderate-affinity, site-specific binding and functional perturbation of HSA, highlighting key factors affecting drug pharmacokinetics and potential delivery strategies in cancer research.

• Angiotensin (1-7): Mechanistic Insight and Translational Pot

  2026-05-05

  Explore the multifaceted biology of Angiotensin (1-7), an endogenous heptapeptide hormone, focusing on its mechanistic role as a Mas receptor agonist and its cross-domain implications. This article offers in-depth analysis and practical guidance for researchers seeking to leverage the unique capabilities of Angiotensin (1-7) in advanced experimental systems.

• Indole-3-pyruvic Acid Modulates Th17/Treg Balance in RA via

  2026-05-05

  This study demonstrates that indole-3-pyruvic acid (IPA) alleviates rheumatoid arthritis by restoring Th17/Treg balance through activation of the aryl hydrocarbon receptor (AhR) pathway. The findings provide mechanistic insight into IPA’s immunomodulatory effects and its translational potential as a probe in autoimmune disease research.

• Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4

  2026-05-04

  Morin’s dual action as an antioxidant and fluorescent probe empowers researchers to dissect oxidative stress and mitochondrial energy dynamics in diabetes, neurodegenerative, and cancer models. This article delivers actionable workflow enhancements, troubleshooting guidance, and cross-domain insights that reflect both recent clinical findings and advanced bench protocols.

• Applied Workflows with (-)-Arctigenin: MEK1 Inhibitor in Onc

  2026-05-04

  (-)-Arctigenin, a potent MEK1 inhibitor, offers reproducible modulation of NF-κB signaling and iNOS expression for cancer and neuroinflammation research. This article delivers stepwise protocols, troubleshooting strategies, and actionable insights—bridging recent microRNA-driven findings with hands-on laboratory optimization.

15542 records 10/1037 page Previous Next First page 上5页 678910 下5页 Last page